- 商品介绍
- 规格参数
- 包装参数
Biochem/physiol Actions
3PO analog with improved PFKFB3 inhibitory potency in vitro and in vivo.
PFK158 is a 3PO analog with improved PFKFB3 inhibitory potency (cell-free IC50 = 137 nM; Jurkat cellular IC50 = 1.62 μM/PFKFB3 activity, 847 nM/2-deoxyglucose uptake, 328 nM/toxicity) and pharmacokinetic properties. PFK158 markedly sensitizes BRAF(V600E)-positive A375 melanoma cells to apoptosis induction by vemurafenib in cultures and causes ~80% growth inhibition in several murine models of human-derived tumors in vivo (60 mg/kg qod. ip.).
| Quality Level | 100 |
| assay | ≥98% (HPLC) |
| form | powder |
| color | white to beige |
| solubility | DMSO: 2 mg/mL, clear (warmed) |
| storage temp. | 2-8°C |
| SMILES string | O=C(/C=C/C1=NC2=C(C=CC(C(F)(F)F)=C2)C=C1)C3=CC=NC=C3 |
| InChI | 1S/C18H11F3N2O/c19-18(20,21)14-3-1-12-2-4-15(23-16(12)11-14)5-6-17(24)13-7-9-22-10-8-13/h1-11H/b6-5+ |
| InChI key | IAJOMYABKVAZCN-AATRIKPKSA-N |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
¥ 1259.40
-
¥ 1563.36
-
询价
-
询价
-
询价
-
询价
-
询价
-
¥ 6894.69
-
¥ 5167.58
-
询价
-
¥ 3812.28
-
¥ 4897.21
-
¥ 2151.46
-
询价
-
¥ 954.17
-
¥ 3662.39
-
¥ 2754.43
-
询价
-
¥ 64659.66
-
¥ 37675.92
微信小程序
7X24小时在线咨询